Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapiesAlessandra Aiello, Andrea Coppola, Serena Ruggieri, Chiara Farroni, Anna Maria Gerarda Altera, Andrea Salmi, Valentina Vanini, Gilda Cuzzi, Linda Petrone, Silvia Meschi, Daniele Lapa, Aurora Bettini, Shalom Haggiag, Luca Prosperini, Simonetta GalganiSee the full list of authors
15 December 2022
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinationsMarton König, Åslaug Rudjord Lorentzen, Hilde Marie Torgauten, The Trung Tran, Stine Schikora-Rustad, Eline Benno Vaage, Åse Mygland, Stig Wergeland, Jan Aarseth, Ingeborg Aase S Aaberge, Øivind Torkildsen, Trygve Holmøy, Tone Berge, Kjell-Morten Myhr, Hanne Flinstad HarboSee the full list of authors
20 October 2021
Impact of tDCS on persistent COVID-19 olfactory dysfunction: a double-blind sham-controlled studyLucilla Vestito, Laura Mori, Carlo Trompetto, Diego Bagnasco, Rikki F Canevari, Marta Ponzano, Davide Subbrero, Ester Cecchella, Cristina Barbara, Piero Clavario, Fabio Bandini
23 May 2022
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestationsDomenico Plantone, Sara Locci, Laura Bergantini, Carlo Manco, Rosa Cortese, Martina Meocci, Dalila Cavallaro, Miriana d'Alessandro, Elena Bargagli, Nicola De Stefano
22 September 2022
)Alexandra Kachaner, Cédric Lemogne, Julie Dave, Brigitte Ranque, Thomas de Broucker, Elodie Meppiel
25 August 2022
Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide studyThomas Williams, Rhea Mishra, Brina Bharkhada, Aoife Shields, Rachel Dorsey, Jeremy Chataway, Wallace J Brownlee
10 March 2022
Parsonage-Turner syndrome following COVID-19 vaccinationYoung Gi Min, Jee-Eun Kim, Ji Young Hwang, Je-Young Shin, Jung-Joon Sung, Yoon-Ho Hong
6 April 2022
Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-upSVIN COVID-19 Global SAH Registry, Thanh N. Nguyen, Muhammad M. Qureshi, Piers Klein, Hiroshi Yamagami, Robert Mikulik, Nima Etminan, Mohamad Abdalkader, Ossama Yassin Mansour, Anna Czlonkowska, Hannah Lo, Anvitha Sathya, Jelle Demeestere, Georgios Tsivgoulis, Nobuyuki SakaiSee the full list of authors
28 July 2022
Consider alternative causes before allocating acute ischaemic stroke to COVID-19Josef Finsterer
4 March 2022
Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: a cross-sectional studyMatthieu Gasnier, Walid Choucha, Francois Radiguer, Theo Faulet, Kenneth Chappell, Aurore Bougarel, Christian Kondarjian, Paul Thorey, Antoine Baldacci, Maryne Ballerini, Abd El Kader Ait Tayeb, Hugo Herrero, Isabelle Hardy-Leger, Olivier Meyrignac, Luc MorinSee the full list of authors
11 August 2022
